Orbimed Advisors LLC Xeris Biopharma Holdings, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 80,420 shares of XERS stock, worth $436,680. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80,420
Previous 80,420
-0.0%
Holding current value
$436,680
Previous $229,000
18.78%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$56.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$42.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$18.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$18.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$15.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $738M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...